Location History:
- Kakamigahara, JP (1987)
- Kani-gun, JP (2020)
Company Filing History:
Years Active: 1987-2020
Title: Katsuhiro Hayashi: Innovator in Pharmaceutical Research
Introduction
Katsuhiro Hayashi is a notable inventor based in Kani-gun, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in cancer therapy. With a total of 2 patents, his work focuses on developing effective therapeutic agents with minimal side effects.
Latest Patents
Hayashi's latest patents include a lenvatinib derivative and a novel resolution method of a racemic mixture. The lenvatinib derivative aims to provide a compound and a tumor therapeutic agent that are highly effective in cancer therapy while reducing the likelihood of hypertension as a side effect. This derivative features a nitric acid ester group, which produces nitric oxide (NO) that has a vasodilating action in vivo. This mechanism allows for a higher concentration of lenvatinib to reach target molecules in cancer cells and vascular endothelial cells, thereby enhancing therapeutic efficacy. The second patent details a novel resolution method of a racemic mixture, where four kinds of salts are dissolved in a resolving solvent to fractionally crystallize a desired optically active isomer through an exchange reaction between counter ions.
Career Highlights
Katsuhiro Hayashi is affiliated with the Institute of Applied Biochemistry, where he continues to advance his research in pharmaceutical innovations. His work has the potential to significantly impact cancer treatment methodologies.
Collaborations
Hayashi collaborates with esteemed colleagues such as Masayasu Kurono and Takafumi Iida, contributing to a dynamic research environment that fosters innovation.
Conclusion
Katsuhiro Hayashi's contributions to pharmaceutical research exemplify the importance of innovation in developing effective cancer therapies. His patents reflect a commitment to improving patient outcomes while minimizing side effects.